Join the HIV Infection group to help and get support from people like you.
HIV Infection News (Page 2)
Related terms: Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency Syndrome (AIDS), Acute HIV Infection, Acute Retroviral Syndrome, AIDS, AIDS-Related Complex, Chronic Symptomatic HIV Infection, HIV Infection, Acute, HIV Seroconversion Syndrome, Human Immunodeficiency Virus Infection, Primary HIV Infection, HIV, ARC, Acquired Immunodeficiency Syndrome, HIV/AIDS
People With HIV Can Now Receive Livers, Kidneys From HIV-Positive Donors
TUESDAY, Nov. 26, 2024 – People with HIV can now receive a potentially life-saving kidney or liver from a donor who is also infected with the virus, according to new rules announced Tuesday by the...
Decline Expected in HIV Care Providers in Next Five Years
FRIDAY, Nov. 8, 2024 – The supply of health care professionals available to provide HIV care is expected to continue to decline over the next five years, according to research published in the...
Preexposure Prophylaxis Use for HIV Increased in Recent Years
MONDAY, Oct. 21, 2024 – Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, according to a research letter published online Oct. 14 in the Journal of the American Medical ...
Kidney Transplants Safe When Donor, Recipient Both HIV-Positive
WEDNESDAY, Oct. 16, 2024 – People living with HIV who need a kidney can rest assured that outcomes are similar whether their kidney donor was also HIV-positive or not, a new study finds. One- and...
Kidney Transplant Noninferior From Donors With Versus Without HIV in HIV-Positive Recipients
THURSDAY, Oct. 17, 2024 – Among recipients with HIV, kidney transplantation from donors with HIV is noninferior to that from donors without HIV, according to a study published online Oct. 16 in the...
Metabolic Risk Contributes to Diabetes Onset in People With HIV
MONDAY, Oct. 7, 2024 – For people with HIV (PWH) with low-to-moderate atherosclerotic cardiovascular disease (ASCVD) risk, metabolic risk factors contribute to new-onset diabetes mellitus (DM) among...
Limited Progress on QoL Goals Reported for Persons With HIV Aged 50 Years and Older
FRIDAY, Sept. 13, 2024 – For persons diagnosed with HIV (PWH) aged 50 years and older, progress on quality of life (QoL) goals is limited, according to a study published online Sept. 12 in Morbidity...
Twice-Yearly Injection Cuts HIV Risk by 96%, But Will Cost Cut Access?
THURSDAY, Sept. 12, 2024 – It could be a real breakthrough for people at risk for HIV infection: A shot given every six months that reduces their risk by a whopping 96%. That's according to new...
Federal Judge Rules That U.S. Military Cannot Reject HIV-Positive Enlistees
FRIDAY, Aug. 23, 2024 – People with HIV can no longer be turned away if they try to enlist in the U.S. military, a federal judge has ruled. The decision, issued this week by U.S. District Judge...
Hep C Reinfection Observed in HIV-Positive Men Who Have Sex With Men
THURSDAY, Aug. 8, 2024 – The incidence rate of hepatitis C virus (HCV) reinfection was 4.7 per 100 person-years among men who have sex with men (MSM) with HIV who cleared HCV, according to a study...
Long-Acting Cabotegravir Well Tolerated in Pregnant Women
THURSDAY, Aug. 8, 2024 – Long-acting injectable cabotegravir (CAB-LA) appears to be well tolerated in pregnant women, according to a study presented at AIDS 2024, the 25th International AIDS...
Twice-Yearly Shot Protects At-Risk Women Against HIV
WEDNESDAY, July 24, 2024 – Just two shots a year of an HIV treatment provided complete protection against infections in highly at-risk women, researchers reported Wednesday. In the study of about...
Long-Acting Early Viral Inhibition Described in Context of Long-Acting Injectable Cabotegravir
MONDAY, July 29, 2024 – In a research letter published online July 24 in the New England Journal of Medicine, the authors describe long-acting early viral inhibition (LEVI) among patients with acute...
Twice-Yearly Lenacapavir Prevents HIV Infection in Young Women
FRIDAY, July 26, 2024 – For adolescent girls and young women, lenacapavir every 26 weeks is beneficial for preventing acquired HIV infection, according to a study published online July 24 in the New...
Twice-Yearly Shot Protects At-Risk Women Against HIV
WEDNESDAY, July 24, 2024 – Just two shots a year of an HIV treatment provided complete protection against infections in highly at-risk women, researchers reported Wednesday. In the study of about...
Further information
Related condition support groups
Pre-Exposure Prophylaxis, Viral Infection
Related drug support groups
Biktarvy, bictegravir / emtricitabine / tenofovir alafenamide, Genvoya, Triumeq